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www.jacctctabstracts2013.com TUESDAY, OCTOBER 29, 2013, 3:30 PM–5:30 PM122.4178.3 mg/dl, p¼0.006), pre-PCI minimal lumen diameter was smaller
(0.190.30mm vs. 0.320.36mm, p¼0.041), pre-PCI diameter stenosis was higher
(93.99.5% vs 89.611.5%, p¼0.037), pre PCI TIMI ﬂow was lower (pre-PCI TIMI
ﬂow non-3; 77.8% vs. 59.3%, p¼0.038), and post-PCI diameter stenosis was higher
(14.65.8% vs. 11.65.0%, p¼0.004). Multivariate analysis revealed peak CK-MB
and EF were independent predictor of TP. During three years of follow up, major
adverse cardiac events (MACE; target vessel revascularization, myocardial infarction,
death) were not different in TP + and TP – groups (11.1% vs. 16.7%, p¼0.404).
Conclusions: Despite of minor angiographic difference, TP was not associated with
three-year MACE in patients with primary coronary stent implantation due to STEMI.
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Background: No randomized studies have been conducted to investigate serial
changes of optical coherence tomography (OCT) ﬁndings following biolimus-A9-
eluting stents (BES) vs. sirolimus-eluting stents (SES) implantation.
Methods: A total of 60 patients fulﬁlling study criteria were randomly assigned into
BES (n¼30) and SES (n¼30) implantation. Of these, serial OCT evaluation at post-
procedure, 3, and 12 months was performed in 46 patients [BES (n¼22) and SES
(n¼24)] and OCT ﬁndings were compared according to the types of stents and fol-
lowed time intervals. The primary endpoint was the percentage of uncovered struts
(ratio of uncovered struts to total struts in all cross-sections with 0.2-mm interval) at 3
and 12 months and the changes (D) of percentages between 3-12 months.
Results: Although the percentages of uncovered struts at 3 months were not signiﬁ-
cantly different between two stents, BES compared to SES showed a signiﬁcantly
higher percentage of uncovered struts on 12-month OCT without signiﬁcant difference
of neointimal thickness (See Figure A). Through serial OCT evaluation, both stents
signiﬁcantly increased strut coverage from 3 to 12 months. However, BES showed
a greater D percentage of uncovered struts between 3-12 months than SES (See
Figure B).difference
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SConclusions: In this randomized serial OCT study, both DESs still showed the
incomplete strut coverage at 3 months but BES compared to SES showed a signiﬁ-
cantly lower prevalence of uncovered struts at 12 months by superior coverage from 3
to 12 months.
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Background: Longitudinal stent deformation (LSD) is a recently reported compli-
cation of coronary intervention. However, to date, the axial integrity of stents has not
been systematically examined. This study aimed to assess the rate of LSD after
implantation utilizing intravascular ultrasound (IVUS).
Methods: A total of 218 drug-eluting stents (DES) of 197 patients with coronary
artery disease who underwent IVUS after implantation for de novo lesions were
included: 32.1% sirolimus-eluting stents (SES); 15.6% paclitaxel-eluting stents (PES);
22.9% cobalt-chromium everolimus-eluting stents (CC-EES); and 29.4% platinum-
chromium everolimus-eluting stents (PC-EES, Element platform). Stent length wasJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrdetermined using automatic pullback of an IVUS catheter. The absolute value of the
difference in length [IVUS-measured stent length – labeled stent length] (mm), and the
absolute value of the relative difference in length [(IVUS-measured stent length –
labeled stent length) divided by labeled length] (%) were analyzed.
Results: There was no signiﬁcant difference with regards to the absolute and relative
differences in stent length among groups. The absolute relative difference of >5% was
the lowest in the SES group compared to the other groups. Signiﬁcant (>15%)
absolute value of the relative difference in stent length was low and similar among
groups. (Table)Conclusions: This IVUS analysis proved that there are no signiﬁcant differences in
axial stent integrity between ﬁrst- and second-generation DES and among second-
generation DES. The anecdotal reports of longitudinal deformation are unsubstanti-
ated in contemporary clinical practice.
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Background: Stent underexpansion is still a concern as a cause of drug-eluting stent
(DES) failure. Although the amount of coronary calciﬁcation is considered as
a contributing factor for stent under expansion, a previous intravascular ultrasound
(IVUS) study failed to demonstrate relation between stent expansion and coronary
calciﬁcation. Optical coherence tomography (OCT) offers better quantitative assess-
ment of coronary calcium than IVUS and therefore may have potential to predict stent
expansion. Thus, the purpose of this study was to investigate whether stent expansion
could be predicted by coronary calciﬁcation assessed by OCT.
Methods: A total of 51 de novo native coronary artery lesions from 44 patients treated
by single 2nd generation DES were enrolled. Prior to stent deployment, arc of calcium
and area of calcium at the maximal calciﬁcation site within the target lesion were
measured using OCT. After successful stent implantation, OCT imaging was repeatedacts/POSTER/Intravascular Imaging and PCI B169
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deﬁned as MSD (or MSA) divided by the values predicted by the manufacturers'
compliance charts. Patients were divided into 4 groups according to the median values
of arc and area of calcium.
Results: Mean stent expansion was 73.3  8.7% for MSD and 65.2  12.0% for
MSA. Stent expansion deﬁned by MSD was signiﬁcantly different among the groups
(p ¼ 0.02) (Figure). Similar trend was observed for stent expansion deﬁned by MSA
(p ¼ 0.16).Conclusions: Stent expansion of the 2nd generation DESs may be predicted by the
amount of target lesion calciﬁcation assessed by OCT.
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Background: To examine the endothelial shear stress (ESS) patterns, the neointimal
distribution and the relation between ESS and neointimal thickness (NT) in models
derived from the integration of frequency domain optical coherence tomographic (FD-
OCT) and coronary angiographic data and compare these estimations with those
computed in the traditional reconstructions obtained by the fusion of intravascular
ultrasound (IVUS) and coronary angiography.
Methods: Six segments implanted with an Absorb Bioresorbable Vascular Scaffold
(Absorb BVS) that were investigated with FD-OCT and IVUS examination at baseline
and 6 or 12 months follow-up were included. The IVUS and OCT data acquired at
follow-up were fused separately with the angiographic data to reconstruct the luminal
surface at baseline and follow-up. Blood ﬂow simulation was performed on the
baseline IVUS-based and OCT-based models and computational ﬂuid dynamics
techniques were implemented to assess the ESS and the association between the ESS
and the measured NT at follow-up.
Results: The IVUS-based models appeared to underestimate the neointima
tissue (0.670.59 mm3 vs. 15.145.63 mm3, P¼0.001) compared to the FD-
OCT-based reconstructions. Flow recirculation zones were detected in the FD-
OCT-based reconstructions and the ESS values were lower compared to the
IVUS-based models (1.290.66 Pa vs. 1.870.66 Pa, P¼0.030). These differ-
ences should be attributed to the poor resolution of IVUS that did not allow
visualization of the protruded struts. A statistically signiﬁcant inverse correlation
was noted between the logarithmic ESS at baseline and the NT at follow-up in all
the FD-OCT-based models which was higher than the correlation reported in 5 of
the 6 IVUS-derived models (mean correlation coefﬁcient: -0.520.19 vs.
-0.100.04, P¼0.028).
Conclusions: It appears that the models derived by the fusion of IVUS and coronary
angiography cannot provide enough detail and are incapable of assessing the micro-
environment and its effect on neointima formation following an Absorb BVS
implantation. FD-OCT reconstruction appears superior to IVUS-based reconstruc-
tions and it should be preferred for studying the effect of ESS on neointimal
proliferation.B170 JACC Vol 62/18/Suppl B j October 27–NoveTCT-564
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Background: The aim of this study is to examine the implications of the local
endothelial shear stress (ESS) on neointimal proliferation following an Absorb Bio-
resorbable Vascular Scaffold (BVS) implantation.
Methods: Twelve patients who had an Absorb BVS implantation in a stenotic,
relatively straight arterial segment and who were investigated with serial optical
coherence tomographic examination at baseline and 1 year follow-up were included in
the current analysis. The optical coherence tomographic data acquired at follow-up
were used to reconstruct the treated segment. Blood ﬂow simulation was performed on
the luminal surface at baseline deﬁned by the Absorb BVS struts and the estimated
ESS was related to the neointima thickness measured at 1year follow-up.
Results: The protruded struts appeared to affect the ESS patterns. Low ESS and recircu-
lation zoneswere noted between the struts areas and highESS zones on the top of the struts.
At baseline, , 61% of the measured ESS were <1 Pa. At follow-up, the mean neointima
thickness was 11345 mmwhile the percentage area obstruction was 13.16.6%. Aweak
but statistically signiﬁcant inverse correlation was noted between baseline ESS and neo-
intima thickness at 1year follow-up in all studied segments (correlation coefﬁcient range:
-0.110 to -0.620). Mixed linear regression analysis between baseline ESS and neointima
thickness at follow-up yielded a slope of -29 mm/Pa and a y-intercept of 142 mm.
Conclusions: The hemodynamic micro-environment appears to regulate neointimal
response following an Absorb BVS implantation. These ﬁndings underline the role of
the ESS patterns on vessel wall healing and should be taken into consideration in the
design of bioresorbable devices.
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Background: Biodegradable stent coatings are hoped to improve the vessel wall
healing. ALEX is a new generation, biodegradable polymer-coated, sirolimus-eluting,
cobalt-chromium coronary stent system.
Methods: A prospective, single arm, multi-centre registry enrolled 60 patients with de
novo native coronary lesions treated with ALEX stent and examined the outcomes by
quantitative coronary analysis (QCA) and optical coherence tomography (OCT) at
multiple timepoints (3 subgroups of 20 patients each at 3, 6 and 12 months) to capture
the time course of vessel healing. Stent strut coverage, stent apposition and neointimal
proliferation were assessed by OCT. Safety endpoint was the composite of death,
myocardial infarction, target lesion re-intervention (TLR) and stent thrombosis (ST) at
30 days and 12 month follow-up.
Results: At baseline, reference vessel diameter was 2.85 (IQR 2.45, 3.17) mm, lesion
length was 12.00 (IQR 9.67,14.58), minimal lumen diameter was 1.020.40 mm and
percent diameter stenosis (%DS) was 6511.5 by QCA. We have treated 31% of
lesions type A/B1 and 69% of lesions type B2/C. Median stent diameter was 3.0 (IQR
2.75, 3.50) mm, stent length was 15 (IQR 12; 20) mm. Procedural device success rate
was 98,7% with post-procedural %DS 6.0 (IQR 2.0; 8.5). QCA analysis revealed
median late lumen loss (mm) 0.035 (IQR -0.047, 0.01) at 3 months, 0.17 (IQR -0.01,
0.32) at 6 months, and 0.14 (IQR 0.07, 0.42) at 12 months. The OCT analysis pre-
sented full strut coverage in 96% at 3 months, in 98% at 6 months, and 100% at 12
months. The rate of uncovered stent struts per section (RUST) >0.3 was 3.15% at 3
months, 1.74% at 6 months, and 0% at 12 months of follow-up, and the malapposition
rate was 0.13%, 0.03% and 0.02%, respectively. There was one death (1,7%), one
TLR (1,7%) and no deﬁnite ST at 12th months of follow-up.
Conclusions: Biodegradable polymer-coated, sirolimus-eluting ALEX stent appears
to feature very favourable proﬁle of arterial wall healing already at 3 months postmber 1, 2013 j TCT Abstracts/POSTER/Intravascular Imaging and PCI
